• DNDi - Best Science for the Most Neglected 20 Years
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • COVID-19
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • HELP Helminth Elimination Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi Southern Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
DNDi - Best Science for the Most Neglected 20 Years
  • DNDi - Best Science for the Most Neglected 20 Years
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • COVID-19
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • HELP Helminth Elimination Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi Southern Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Events

ICOPA XIII

10-15 August 2014

Mexico City, Mexico

Share on twitter
Share on facebook
Share on linkedin
Share on email
Share on print

The ICOPA congress slogan “ancient parasites, old hosts, new knowledge” points to long lasting parasites, longevity of hosts and the new data shared during ICOPA. The ICOPA program includes symposia with invited speakers who were recommended by outstanding scientists around the world, by Presidents of National Societies of Parasitology, the International Scientific Advisory Board and the local scientific committee; all of them with the highest records in productivity.

DNDi presented and participated in symposia and satellite meetings at ICOPA.

  • Download DNDi @ ICOPA 2014

Opening Ceremony

Opening Address: Dr Bernard Pécoul, Executive Director, DNDi

  • R&D for Neglected Patients: Evolution over a Decade and Future Perspectives on Access & Innovation [PDF | 6.3MB]
  • Chagas Disease: A Silent Emergency [Video]

 

DNDi Symposia

1. Chagas Disease: Advances from discovery to access

Date: Tuesday, August 12, 2014
When: 16:00 – 17:30
Where: Salón Chapultepec B, Hotel Camino Real Polanco

Chair: Roberto Tapia-Conyer, Director General, Carlos Slim Foundation

Eric Chatelain, Head of Drug Discovery, DNDi
Challenges in Chagas drug discovery: in vitro and in vivo models [PDF | 2MB]
Isabela Ribeiro, Head of Chagas Programme, DNDi
New treatment opportunities for Chagas [PDF | 1MB]
Maria Elena Bottazzi, Associate Dean, National School of Tropical Medicine, Baylor College of Medicine
Slim Initiative for vaccine development against tropical diseases: Recent advances on the development of a therapeutic vaccine against Chagas disease
Judith Herrera, Director Medical Department, Médecins Sans Frontières Spain
Ubaldo Mendoza Ambrosio, de Puerto Ángel, Pochutla, Chagas patient
Scaling up diagnostics and treatment of Chagas disease [PDF | 4.8MB]

2. Drug Discovery for Kinetoplastids

Date: Wednesday, August 13, 2014
When: 14:30 – 16:00
Where: Salón Camelias, Hotel Camino Real Polanco

Chair: Richard Glynne, Director of Genetics and Neglected Diseases, Genomics Institute of the Novartis Research Foundation (GNF)

Charles Mowbray, Head of Drug Discovery, DNDi
New mechanisms to accelerate drug discovery for NTDs [PDF | 1.2MB]
Luiz Carlos Dias, Head Professor, Institute of Chemistry, UniCamp
Lead Optimization Latin America (LOLA): consortium models for drug discovery in endemic and emerging countries [PDF | 1.2MB]
James Mills, Computational Chemist, Co-founder and Partner at Sandexis and Owner at Bespoke Comp Chem Ltd.
New computational tools in screening against NTDs [PDF | 0.8MB]
José Maria Fiandor-Roman, Director de Unidad de Investigación, GSK Tres Cantos
New ways of working in the discovery of new medicines for diseases of the developing world


3. Challenges in Leishmaniasis Control

Date: Thursday, August 14, 2014
When: 
14:30 – 16:00
Where: 
Salón Terraza C, Hotel Camino Real Polanco

Chair: Daniel Argaw, Head of Leishmaniasis Program, Department of Control of Neglected Tropical Diseases, World Health Organization

Bhawna Sharma, Director of R&D Operations, DNDi India
Elimination of VL in the Indian subcontinent: Is it achievable? [PDF | 0.5MB]
Fabiana Alves, Clinical Manager, DNDi
Pitfalls in VL treatment: Regional differences and challenges [PDF | 1.1MB]
Manu Vanaerschot, Institute of Tropical Medicine – Antwerp
Treatment failure, drug resistance and VL control in the Indian subcontinent: lessons learnt from a multidisciplinary research project (Kaladrug-R) [PDF | 0.8MB]
Byron Arana, Head of Cutaneous Leishmaniasis Programme, DNDi
Challenges in CL: Perspectives of treatment development and disease control [PDF | 0.8MB]
Carlos Slim Foundation Symposium


Viewpoints of public policies in parasitology: Protozoa

Date: Wednesday, August 13, 2014
When: 16:00 – 17:30
Where: Terraza C, Hotel Camino Real Polanco

Chair: Roberto Tapia-Conyer, Director General, Carlos Slim Foundation

Peter Hotez, National School of Tropical Medicine at Baylor College of Medicine, Sabin Vaccine Institute, and Texas Children’s Hospital Center for Vaccine Development
Shaping an evidence-based policy agenda for NTDs in the Americas
Eric Stobbaerts, Regional Executive Director, DNDi Latin America
Towards new mechanisms of innovation: How Latin America can become a R&D leader in the field of neglected diseases [PDF | 2.1MB]
Antonio Montresor, Department of Control of Neglected Tropical Diseases, World Health Organization
On track for 2020 NTD roadmap targets
Miguel Betancourt, Director de Soluciones Globales, Instituto Carlos Slim de la Salud
An innovative model for strengthening research and development of vaccines against NTDs

Symposium

Drugs for neglected diseases

Date: Thursday, August 14, 2014
Chair:
 Reto Brun, Scientific Project Leader, Swiss TPH

Fabiana Alves, Clinical Manager, DNDi
Seeking for alternative treatments for visceral leishmaniasis [PDF | 0.7MB]
Side Meetings

Friday, 8 August 2014

Closed meeting
Lessons Learned in the Management of Clinical Trials of Therapeutic Alternatives for Chagas
When: 9:00 – 13:00
Where: Hotel Genève
Closed meeting
New Tools for Diagnostic and Evaluation of Chagas Patients Meeting (NHEPACHA)
When:
 14:00 – 18:00
Where:
 Hotel Genève
Welcome Cocktail: Chagas Clinical Research Platform Annual Meeting
When: 19:00 – 21:00
Where: Patio, Hotel Genève


Saturday, 9 August 2014

Closed meeting
Chagas Clinical Research Platform Annual Meeting
ICOPA pre-congress
When: 8:30 – 17:00
Where: Room Chapultec, Hotel Camino Real Polanco


Sunday, 10 August 2014

Closed meeting
Chagas Experimental Animal Models for Drug Discovery
ICOPA pre-congress
When: 8:30 – 17:00
Where: Room Morelia, Hotel Camino Real Polanco

Cocktail: Chagas Global Coalition

Date: Monday, 11 August 2014
When: 19:00 – 21:00
Where: China Grill, Toy Garden area, Hotel Camino Real Polanco

Raising our voices!
Changing the paradigm for access to diagnosis and treatment of patients living with Chagas disease

Panellists: Pablo Kuri Morales, Secretaria de la Salud, Mexico; Bernard Pécoul, Executive Director, DNDi; Igor Almeida, University of Texas; Elvira Fernandez Cuevas, AMEPACH

Sand art storytelling: Shelly Xie

Special photo exhibition

 Press Releases

[Mexico City, Mexico – 12 August 2014]
New Drug Candidate for Chagas Disease Tested in Patients in Bolivia
Phase II Trial Launched to Test Safety and Efficacy of ‘Rediscovered’ Fexinidazole in 140 Adults with Chronic Indeterminate Chagas Disease
The Drugs for Neglected Diseases initiative (DNDi) announced today at the International Congress of Parasitology (ICOPA), the launch of a Phase II drug trial to test fexinidazole, a drug shelved in the 1980s and ‘rediscovered’ by DNDi nearly a decade ago, for Chagas disease patients. The drug is also being tested in patients in Africa for two other parasitic diseases, sleeping sickness and visceral leishmaniasis.
[Español] [Português]
More

[Mexico City, Mexico – 11 August 2014] 
The Global Chagas Disease Coalition stages high-level event to encourage increased access to diagnosis and treatment of patients fighting Chagas disease
Of the 8 million people infected in the world, 1 million are Mexican
At the 2014 International Congress of Parasitology (ICOPA), the Global Chagas Disease Coalition launched the event “Let’s Raise Our Voice” to alert the world that of the 8 million patients infected with Chagas disease, 99% have not been treated. The aim of this event is to promote an alliance among governments, civil society, doctors, researchers, and patients to discuss simple actions that can be taken to boost patient access to diagnosis and treatment.
[Español] [Português]
More

Videos

DNDi released new videos on Chagas disease and cutaneous leishmaniasis during the conference:

Chagas Disease: A Silent Emergency
The Mark of Neglect: Cutaneous Leishmaniasis

Other events

Loading...
8-12 May 2023

Lisbon, Portugal and online

ESPID 2023

13 April 2023, 2 PM London

London, United Kingdom

Ending the neglect of Chagas disease in the UK

11-12 April 2023

Barcelona, Spain and online

XVIII Jornadas sobre la enfermedad de Chagas

27-31 March 2023

Online

Global meeting on skin-related neglected tropical diseases

See all

Stay connected

Get our latest news, personal stories, research articles, and job opportunities. 

DNDi - Best Science for the Most Neglected 20 Years
Facebook-f
Twitter
Instagram
Linkedin-in
Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License   
We use cookies to track our audience and improve our content. By clicking 'Accept All', you are agreeing to our use of cookies. Click on 'Customize' to accept only some cookies.
Customize
REJECT ACCEPT ALL
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-advertisement1 yearSet by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
CookieLawInfoConsent1 yearRecords the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
PHPSESSIDsessionThis cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
CookieDurationDescription
elementorneverThis cookie is used by the website's WordPress theme. It allows the website owner to implement or change the website's content in real-time.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
CookieDurationDescription
_ga2 yearsThe _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_ga_16Q5RH3XRG2 yearsThis cookie is installed by Google Analytics.
_gat_UA-10302561-11 minuteA variation of the _gat cookie set by Google Analytics and Google Tag Manager to allow website owners to track visitor behaviour and measure site performance. The pattern element in the name contains the unique identity number of the account or website it relates to.
_gid1 dayInstalled by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.
_hjAbsoluteSessionInProgress30 minutesHotjar sets this cookie to detect the first pageview session of a user. This is a True/False flag set by the cookie.
_hjFirstSeen30 minutesHotjar sets this cookie to identify a new user’s first session. It stores a true/false value, indicating whether it was the first time Hotjar saw this user.
_hjIncludedInPageviewSample2 minutesHotjar sets this cookie to know whether a user is included in the data sampling defined by the site's pageview limit.
_hjIncludedInSessionSample2 minutesHotjar sets this cookie to know whether a user is included in the data sampling defined by the site's daily session limit.
_hjSession_112884430 minutesHotjar sets this cookie.
_hjSessionUser_11288441 yearHotjar sets this cookie.
CONSENT2 yearsYouTube sets this cookie via embedded youtube-videos and registers anonymous statistical data.
Targeting
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
SAVE & ACCEPT
Powered by CookieYes Logo